Benzinga’s Top Pre-Market Losers (FLIR, PEP, SWIR, ELON, CADX)
FLIR Systems, Inc. (NASDAQ: FLIR) decreased 3.44% to $28.65 in the pre-market session. FLIR Systems reported today a fourth quarter earnings of $60.3 million, or $0.38 per share, as compared to $65 million, or $0.41 per share, for the same quarter last year. The 52-week trading range for FLIR is $18.81 - $33.35. FLIR has gained over 37% in the last six months.
PepsiCo, Inc. (NYSE: PEP) declined 0.63% to $60 in the pre-market session. PepsiCo reported today a fourth-quarter net income of $1.4 billion, or $0.90 per share, as compared to $719 million, or $0.46 per share, in the year-ago period. Net revenue increased to $13.3 billion from $12.7 billion in the year ago period. PepsiCo closed at $60.38 in the last trading session. The 52-week trading range for PEP is $45.39 - $64.48.
Sierra Wireless, Inc. (USA) (NASDAQ: SWIR) plunged 16.24% to $9.85 in the pre-market session. Sierra Wireless announced yesterday that for the first quarter of 2010, it expects revenue of $150.0 million, earnings from operations of $3.5 million, net earnings of $3.3 million and diluted earnings per share of $0.11. The 52-week trading range for SWIR is $2.64 - $13.02. SWIR has climbed over 140% in the last year.
Echelon Corporation (NASDAQ: ELON) plunged 17.27% to $6.61 after Echelon Corporation announced yesterday that for the first quarter of 2010, it expects total revenue to be around $15.0 million to $17.0 million, non-GAAP loss per share to be $0.25 to $0.27 and GAAP loss per share to be in between $0.32 and $0.35. ELON closed at $7.99 in the last trading session. In the last six months, ELON declined over 20%.
Cadence Pharmaceuticals, Inc. (NASDAQ: CADX) plummeted 10.51% to $9.25 in the pre-market session. Cadence Pharmaceuticals announced today that the U.S. Food and Drug Administration have issued a Complete Response letter to its New Drug Application for intravenous acetaminophen. The 52-week trading range for CADX is $5.68 - $12.68. Cadence Pharmaceuticals has gained over 31% in the last year.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted-In: Pre-Market Outlook Trading Ideas